FDA Race/Ethnicity Data Guide Retains OMB Terms Despite Industry Criticism
Executive Summary
FDA's final guidance for collecting and reporting race and ethnicity data in clinical trials retains Office of Management & Budget definitions despite industry concerns about applying the categories abroad